|
|
Schrodinger Inc 's Yearly Income from Continued Operations Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
|
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
|
SDGR Annual Income from Cont. Operations Growth |
2023
|
2022
|
2021
|
2020
|
|
Y / Y Annual Income from Cont. Operations Change |
- |
- |
- |
- |
- |
Annual Income from Cont. Operations (in millions $) |
$40.72 |
$-149.19 |
$-101.22 |
$-26.64 |
$0.00 |
Annual Income from Cont. Operations Growth
Comment |
In the fiscal year ended 2023, company achieved Annual Income from Cont. Operations of $40.72 millions compare to loss from Cont. Operations of $-149.19 millions realized a year before.
Schrodinger Inc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2023 Annual Income from Cont. Operations within Healthcare Sector | Y/Y Income from Continued Operations Growth % | 2023 Annual Income from Cont. Operations | Merck and Co Inc | -97.49 % | $ 365.000 millions | Avantor Inc | -53.23 % | $ 321.100 millions | Revvity Inc | -64.99 % | $ 179.503 millions | Catalent Inc | | | |